Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Cantor Fitzgerald Starts Braveheart Bio (BRVE) at Overweight
• Gap (GAP) Reiterated at Buy by UBS as EPS Growth Rate Expected to Inflect Positiively
• H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)